NovaBay Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
NBY
CUSIP
66987P409
All holders as of
Q4 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 66987P409 since 12/18/2024, newest first.

Filer % of Class Filed
R01 Fund LP 13D/A Amendment 3
58.1% 4/2/2026
Event 3/31/2026
Poplar Point Capital Management LLC 13D/A Amendment 3
0.8% 3/11/2026
Event 10/20/2025
David E. Lazar 13D/A Amendment 2 4.99% 1/29/2026
Event 10/21/2025
Framework Ventures IV L.P. 13D/A Amendment 2
45.0% 1/21/2026
Event 1/16/2026
R01 Fund LP 13D/A Amendment 2
45.0% 1/21/2026
Event 1/16/2026
R01 Fund LP 13D/A Amendment 1
45.1% 10/20/2025
Event 10/16/2025
Framework Ventures IV L.P. 13D/A Amendment 1
45.1% 10/20/2025
Event 10/16/2025
David E. Lazar 13D/A Amendment 1 20.0% 10/17/2025
Event 10/16/2025
Poplar Point Capital Management LLC 13D/A Amendment 2
17.5% 10/17/2025
Event 10/15/2025
R01 Fund LP 13D
16.2% 10/15/2025
Event 10/9/2025
Framework Ventures IV L.P. 13D
16.2% 10/15/2025
Event 10/9/2025
Poplar Point Capital Management LLC 13D/A Amendment 1
17.5% 9/4/2025
Event 9/3/2025
David E. Lazar 13D 20.0% 8/26/2025
Event 8/19/2025
Poplar Point Capital Management LLC 13D
17.5% 6/4/2025
Event 6/3/2025
Poplar Point Capital Management LLC 13G/A Amendment 2
16.7% 5/15/2025
Event 3/31/2025
Poplar Point Capital Management LLC 13G/A Amendment 1
12.7% 2/6/2025
Event 1/31/2025
Poplar Point Capital Management LLC 13G
7.7% 1/10/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q4 26 6.09 M $34.4M
2025 Q3 14 227 k $290k
2025 Q2 14 219 k $127k
2025 Q1 19 362 k $212k
2024 Q4 17 167 k $101k
2024 Q3 14 126 k $87.5k
2024 Q2 9 11.5 k $25.4k